Päivi Östling

Päivi Östling

Principal researcher

I am a biochemist by training, now focusing on precision medicine research and implementation. My motivation lies in my deep wish to safely implement our technological advances to benefit patients.

About me

Päivi Östling has more than 10 years of research experience in the field of precision cancer medicine (PCM) research. As of 2016, she has been responsible for establishing a functional precision medicin (fPM) platform at SciLifeLab through the Olli Kallioniemi research group where she also acts as a co-principal investigator. The groups research focuses on individualized drug profiling including multi-omics in acute myeloid leukemia, ovarian and bladder cancer as well as pediatric tumors. She is active within the PCM program of KI and since June 2021, she is one of the Scientific Leads of Precision Medicine at SciLifeLab. 

Research description

My research is on precision cancer medicine in bladder cancer. The aim is to link spatial tissue maps with drug sensitivity and molecular profiles to understand treatment responses.


2016 Associate Professor in Biochemical Systems Biology, Faculty of Science and Engineering, Åbo Akademi University, Finland

2006 - 2011 Postdoctoral training, Medical Biotechnology, VTT, Finland

2006 PhD Turku Centre for Biotechnology, Åbo Akademi University, Finland

1999 MSc Biochemistry, Faculty of Biochemistry and Pharmacy, Åbo Akademi University, Finland

Academic honours, awards and prizes

2023 National infrastructure to support clinical trials in precision medicine with cutting edge technologies, Vetenskapsrådet

2022 Testing and Experimenting Facility Health (TEF-Health) DIGITAL-2022-CLOUD-AI-02

2022 Building a sustainable European Innovation platform to enhance the repurposing of medicine for all - Remedi4all  Horizon Europe, Research and Innovation Actions. PI of demonstrator project on " Validation drugs and combinations for novel host targets in SARS-Cov-2 infection used to build the platform" 

2022 Radiumhemmets forskningsfonder ”Individualied therapy selection for muscle invasive bladder cancer” 2021 Knut and Alice Wallenberg Foundation SciLifeLab National Covid-19 Research Program: AI-driven drug and target prioritization for Covid-19 in collaboration with Charlotte Stadler, Emma Lundberg and Ola Spjuth

2021 Vinnova testbed grant: Precision care bringing technology innovation into oncology (PRIO), PI: Janne Lehtiö 

2021 Miltons donationsfond grant: Spatial single cell maps of bladder cancer microenvironment - implications for prognosis and treatment

2020 Knut and Alice Wallenberg Foundation SciLifeLab National Covid-19 Research Program: Spatial single-cell mapping of SARS-Cov2 interacting host proteins for quick and targeted drug repurposing PI: Charlotte Stadler 

2019 Lillian Sagen och Curt Ericssons fond: A roadmap to a clinical testbed for precision cancer medicine

2018 Vinnova challenge-driven innovation, stage 2: Nanoscale drug testing: Sweden as a testbed for revolutionizing drug discovery PI: Olli Kallioniemi, project lead Brinton Seashore-Ludlow